Delinia grabs $35 mln Series A

Cambridge, Massachusetts-based Delinia, which is developing new treatments for autoimmune diseases, has raised $35 million in Series A funding. Sofinnova Partners and Atlas Venture led the round.

North AmericaUSBriefs